113 related articles for article (PubMed ID: 157569)
1. Suppressor cells and loss of in vitro killer cell inductiveness to donor cells in the peripheral blood lymphocytes of allograft recipients.
Dossetor JB; Liburd EM; Kovithavongs T; Pazderka V
Transplant Proc; 1979 Jun; 11(2):1260-2. PubMed ID: 157569
[No Abstract] [Full Text] [Related]
2. In vitro generation of suppressor cells in human mixed leukocyte culture: a potential treatment modality in organ transplantation.
Miller J; Clark C; Flaa C
Transplant Proc; 1979 Mar; 11(1):899-903. PubMed ID: 156438
[No Abstract] [Full Text] [Related]
3. [Evidence of a specific defect in effector cell formation following kidney and liver allotransplants in humans].
Wonigkeit K; Pichlmayr R
Chir Forum Exp Klin Forsch; 1977 Apr; ():269-73. PubMed ID: 156112
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the immunosuppressive effect of fractionated total lymphoid irradiation (TLI) vs conventional immunosuppression (CI) in renal cadaveric allotransplantation.
Waer M; Vanrenterghem Y; Ang KK; Van der Schueren E; Michielsen P; Vandeputte M
J Immunol; 1984 Feb; 132(2):1041-8. PubMed ID: 6228588
[TBL] [Abstract][Full Text] [Related]
5. Kidney transplantation by use of splenectomy and transfusions, cadaver haplotype matching, suppressor cell assays, and T-cell monitoring.
Severyn W; Kyriakides G; Fuller L; Esquenazi V; Flaa C; Olson L; Goldsmith C; Miller J
Surgery; 1981 Aug; 90(2):364-75. PubMed ID: 6454982
[TBL] [Abstract][Full Text] [Related]
6. [Immunologic monitoring of transplantation patients: study of the reactivity of cytotoxic precursor cells].
Wonigeit K; Pichlmayr R
Chir Forum Exp Klin Forsch; 1978; (1978):271-4. PubMed ID: 378604
[TBL] [Abstract][Full Text] [Related]
7. In vivo - in vitro correlates of antithymocyte globulin (ATG) immunosuppression in the human.
Thomas F; Berry R; Mendez-Picon G; Thomas J; Lower RR; Lee HM
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():56-61. PubMed ID: 386321
[No Abstract] [Full Text] [Related]
8. Suppressor cells inhibiting the generation of cytotoxic T lymphocytes in long-term human transplant recipients.
Thomas J; Johns C; Hoffmann S; Thomas F; Lee HM
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():87-9. PubMed ID: 158755
[No Abstract] [Full Text] [Related]
9. Posttransplant changes in specific precursor T-cell reactivity: comparison between liver and kidney allograft recipients.
Wonigeit K; Bockhorn H; Pichlmayr R
Transplant Proc; 1979 Jun; 11(2):1250-5. PubMed ID: 382500
[No Abstract] [Full Text] [Related]
10. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
[TBL] [Abstract][Full Text] [Related]
11. Donor-specific suppressor cells and donor-specific loss of cell-mediated lympholysis in renal allograft recipients: a comparative study.
Mathew M; Kovithavongs T; Dossetor JB
Transplant Proc; 1984 Dec; 16(6):1478-80. PubMed ID: 6239420
[No Abstract] [Full Text] [Related]
12. Natural killer cell subsets and alloresponsiveness in renal allograft recipients.
Shabtai M; Waltzer WC; Pullis CK; Raisbeck AP; Malinowski K; Rapaport FT
Transplant Proc; 1990 Aug; 22(4):1846-8. PubMed ID: 2143863
[No Abstract] [Full Text] [Related]
13. Changes in peripheral T-cell subsets and natural-killer cytotoxicity in relation to colorectal cancer surgery.
Tartter PI; Martinelli G; Steinberg B; Barron D
Cancer Detect Prev; 1986; 9(3-4):359-64. PubMed ID: 3488807
[TBL] [Abstract][Full Text] [Related]
14. Study of antibody dependent cellular cytotoxicity (ADCC). II. ADCC activity in renal graft recipients and acute accelerated graft rejection.
Wasik M; Gradowska L; Lao M; Rowińska D; Orłowski T
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):311-4. PubMed ID: 373680
[TBL] [Abstract][Full Text] [Related]
15. Evidence for suppressor cells and reduced CML induction by the donor in transplant patients.
Liburd EM; Pazderka V; Kovithavongs T; Dossetor JB
Transplant Proc; 1978 Sep; 10(3):557-61. PubMed ID: 152490
[No Abstract] [Full Text] [Related]
16. Effects of histocompatibility testing versus immunoreactive predisposition on kidney transplant survival.
Kyriakides GK; Severyn W; Fuller L; Esquenazi V; Flaa C; Olson L; Miller J
Surgery; 1982 Aug; 92(2):354-61. PubMed ID: 6213054
[TBL] [Abstract][Full Text] [Related]
17. Natural killer activity against viral targets in cyclosporine-treated renal allograft recipients.
Cauda R; Citterio F; Tamburrini E; Pozzetto U; Tumbarello M; Castagneto M; Ortona L
Transplant Proc; 1988 Apr; 20(2 Suppl 2):186-9. PubMed ID: 2834839
[No Abstract] [Full Text] [Related]
18. In vitro and in vivo immunosuppressive activity of amniotic fluid in the rat.
Matsui S; Yoshimura N; Oka T
Transplant Proc; 1989 Apr; 21(2):3307-8. PubMed ID: 2523607
[No Abstract] [Full Text] [Related]
19. The role of methylprednisolone in the modulation of cellular cytotoxicity and its relation to renal transplantation.
Keown P; Stiller C; Ulan R; Lockie C; McGirr D
Proc Eur Dial Transplant Assoc; 1978; 15():299-305. PubMed ID: 154100
[TBL] [Abstract][Full Text] [Related]
20. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH
J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
